Literature DB >> 15735727

Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation.

Thomas R Berton1, David L Mitchell, Ruifeng Guo, David G Johnson.   

Abstract

The E2F1 transcription factor regulates the expression of genes involved in cell proliferation, apoptosis and DNA repair. Following DNA damage, E2F1 is phosphorylated and stabilized, but the physiological role of E2F1 in the response to DNA damage is unclear. We find that mice lacking E2F1 have increased levels of epidermal apoptosis compared to wild-type mice following exposure to ultraviolet B (UVB) radiation. Moreover, transgenic overexpression of E2F1 in basal layer keratinocytes suppresses apoptosis induced by UVB. Inhibition of UVB-induced apoptosis by E2F1 is unexpected given that most studies have demonstrated a proapoptotic function for E2F1. E2F1-mediated suppression of apoptosis does not involve alterations in mitogen-activated protein kinase activation or Bcl-2 downregulation in response to UVB and is independent of p53. Instead, inhibition of UVB-induced apoptosis by E2F1 correlates with a stimulation of DNA repair. Mice lacking E2F1 are impaired for the removal of DNA photoproducts, while E2F1 transgenic mice repair UVB-induced DNA damage at an accelerated rate compared to wild-type mice. These findings suggest that E2F1 participates in the response to UVB by promoting DNA repair and suppressing apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735727     DOI: 10.1038/sj.onc.1208462

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  E2F1 localizes to sites of UV-induced DNA damage to enhance nucleotide excision repair.

Authors:  Ruifeng Guo; Jie Chen; Feng Zhu; Anup K Biswas; Thomas R Berton; David L Mitchell; David G Johnson
Journal:  J Biol Chem       Date:  2010-04-22       Impact factor: 5.157

Review 2.  Keratinocyte apoptosis in epidermal development and disease.

Authors:  Deepak Raj; Douglas E Brash; Douglas Grossman
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

3.  pRB-E2F1 complexes are resistant to adenovirus E1A-mediated disruption.

Authors:  L A Seifried; S Talluri; M Cecchini; L M Julian; J S Mymryk; F A Dick
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

4.  The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.

Authors:  Patrick S Lin; Lisa A McPherson; Aubrey Y Chen; Julien Sage; James M Ford
Journal:  DNA Repair (Amst)       Date:  2009-04-18

5.  E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks.

Authors:  Jie Chen; Feng Zhu; Regina L Weaks; Anup K Biswas; Ruifeng Guo; Yanjie Li; David G Johnson
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

6.  p53: Guardian of pancreatic epithelial identity.

Authors:  Bidyut Ghosh; Steven D Leach
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

7.  E2F1 and E2F2 induction in response to DNA damage preserves genomic stability in neuronal cells.

Authors:  Daniela S Castillo; Anna Campalans; Laura M Belluscio; Abel L Carcagno; J Pablo Radicella; Eduardo T Cánepa; Nicolás Pregi
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Division and apoptosis of E2f-deficient retinal progenitors.

Authors:  Danian Chen; Marek Pacal; Pamela Wenzel; Paul S Knoepfler; Gustavo Leone; Rod Bremner
Journal:  Nature       Date:  2009-12-17       Impact factor: 49.962

9.  E2F1 regulates the base excision repair gene XRCC1 and promotes DNA repair.

Authors:  Dexi Chen; Zhiyong Yu; Zhiyi Zhu; Charles D Lopez
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

10.  Mifepristone abrogates repopulation of ovarian cancer cells in between courses of cisplatin treatment.

Authors:  Elizabeth M Freeburg; Alicia A Goyeneche; Carlos M Telleria
Journal:  Int J Oncol       Date:  2009-03       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.